Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Andorra Health Watch.
Press releases published on September 18, 2025
Compass Health Celebrates Grand Opening of Marc Healing Center
EVERETT, Wash., Sept. 18, 2025 (GLOBE NEWSWIRE) -- After years of purposeful design, hard work and passionate community support, Compass Health celebrated the grand opening of the Marc Healing Center: the region’s newest state-of-the-art facility for …
Ceramics Industry Set for Strong Growth, Projected to Reach $62.5 Billion by 2030
Boston, Sept. 18, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Ceramics Markets: A BCC Research Outlook” is expected to grow from $41.3 billion in 2025 to $62.5 billion by the end of 2030, at a compound annual growth rate …
Alameda Health System is recognized for responsible sourcing and sustainable procurement
OAKLAND, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Alameda Health System (AHS) has been recognized as a top performer by Vizient® in its 2025 Responsible Sourcing Ranking. This honor is in recognition of AHS' sustainable procurement practices that drive …
Immix Biopharma Announces 50% Enrollment Milestone Surpassed in its ongoing relapsed/refractory AL Amyloidosis Clinical Trial, NEXICART-2
– On track for first FDA Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL Amyloidosis – Los Angeles, CA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ” …
Chronic Venous Insufficiency Market to Increase at a CAGR of 9.4% During the Forecast Period (2025–2034) Due to the Launch of Emerging Therapies and Chronic Venous Insufficiency Medical Devices | DelveInsight
New York, USA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Chronic Venous Insufficiency Market to Increase at a CAGR of 9.4% During the Forecast Period (2025–2034) Due to the Launch of Emerging Therapies and Chronic Venous Insufficiency Medical Devices | …
Global Overactive Bladder Treatment Market to Exhibit Substantial Growth at a CAGR of ~4% by 2032 | DelveInsight
New York, USA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Global Overactive Bladder Treatment Market to Exhibit Substantial Growth at a CAGR of ~4% by 2032 | DelveInsight The overactive bladder treatment market is experiencing steady growth driven by the …
Toni Pashley joins Scene Health as Chief Product Officer to help solve the Medication Adherence challenge
BALTIMORE, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Scene Health, a leader in MedEngagement, welcomes Toni Pashley as its new Chief Product Officer (CPO), marking a transformative moment for Scene as they accelerate their technological innovations to support …
Kuros statement on media inquiry concerning former Board member
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros statement on media inquiry concerning former Board member Schlieren (Zurich), Switzerland, September 18, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next …
OrganOx metra® Receives FDA Approval for Operation During Air Transport, Expanding Access to Life-Saving Liver Perfusion Technology
OrganOx Ltd., the organ technology company tackling the world's toughest transplant challenges, announced that its metra® normothermic machine perfusion (NMP) device has received approval from the U.S. Food and Drug Administration (FDA) for operation …
What to know about Medicare changes before you shop for a 2026 plan
Minneapolis, MN, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Millions of Americans will soon have the chance to make critical decisions about their health coverage during the upcoming annual Medicare open enrollment period. Health policy analysts at …
Dark Horse Consulting Group Acquires Converge Consulting
WALNUT CREEK, Calif. and CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational consulting in advanced therapies—specifically the fields of cell and gene therapy (“CGT …
eHealth Exchange 2025 Annual Meeting To Spotlight Innovation, AI, and Future of Interoperability
VIENNA, Va., Sept. 18, 2025 (GLOBE NEWSWIRE) -- In a time when healthcare is being reimagined with advances in artificial intelligence (AI), data exchange, and policy, the eHealth Exchange™ annual meeting will convene leaders, innovators, and trailblazers …
Penn Highlands Healthcare Clinicians Pioneer Opioid-Free ACL Surgery Protocol for Young Athletes
DuBois, Pennsylvania, Sept. 18, 2025 (GLOBE NEWSWIRE) -- In a bold move to combat the opioid crisis and advance surgical recovery, the Orthopedics and Sports Medicine team at Penn Highlands Healthcare has developed a pioneering approach to ACL surgery that …
After Transforming Neuro Care, Sevaro Secures $39M to Expand AI-Powered Specialty Care Platform
NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Sevaro Health, the company transforming neurological care in the United States, today announced the close of a $39 million oversubscribed Series B funding round. The round was led by Valtruis, an investment …
Senti Bio to Present at the MedInvest Biotech & Pharma Conference
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, …
Replimune Provides Update Following Type A Meeting with FDA
WOBURN, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company completed a Type A meeting with …
BioCardia Announces Pricing of Up To $12 Million Public Offering
SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA] (“BioCardia” or the “Company”), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the …
Safety Shot Provides Further Details on Strategic Board Refresh and Corporate Vision
Company to Seek Shareholder Approval for New Director Appointments SCOTTSDALE, AZ, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Following its announcement yesterday regarding a strategic refresh of its Board of Directors, Safety Shot, Inc. (Nasdaq: SHOT) is …
Scientific Industries to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
BOHEMIA, N.Y., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, today announced that it will participate in a webcast presentation and …